Where and by whom should gastric cancer HER2/neu status be assessed? Lessons from breast cancer

Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/108627

DC Field	Value
dc.title	Where and by whom should gastric cancer HER2/neu status be assessed? Lessons from breast cancer
dc.contributor.author	Salto-Tellez, M.
dc.contributor.author	Yau, E.X.
dc.contributor.author	Yan, B.
dc.contributor.author	Fox, S.B.
dc.date.accessioned	2014-11-25T09:48:25Z
dc.date.available	2014-11-25T09:48:25Z
dc.date.issued	2011-06
dc.identifier.citation	Salto-Tellez, M.,Yau, E.X.,Yan, B.,Fox, S.B. (2011-06). Where and by whom should gastric cancer HER2/neu status be assessed? Lessons from breast cancer. Archives of Pathology and Laboratory Medicine 135 (6) : 693-695. ScholarBank@NUS Repository.
dc.identifier.issn	00039985
dc.identifier.uri	http://scholarbank.nus.edu.sg/handle/10635/108627
dc.source	Scopus
dc.type	Editorial
dc.contributor.department	CANCER SCIENCE INSTITUTE OF SINGAPORE
dc.contributor.department	PATHOLOGY
dc.description.sourcetitle	Archives of Pathology and Laboratory Medicine
dc.description.volume	135
dc.description.issue	6
dc.description.page	693-695
dc.description.coden	ARPAA
dc.identifier.isiut	NOT_IN_WOS
Appears in Collections:	Staff Publications

There are no files associated with this item.

Check